Trial ID
ES002023-1001
Sponsor ID
Elpiscience Biopharma
An Open-Label, Mulitcenter, First-in-Human, Dose Escalation, Phase 1 Study of ES002023 in Patients with Locally Advanced or Metastatic Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
TSC-007
Sponsor ID
PRECISION-1
A Phase 2 multi-center open-label basket trial of ABI-009 (nab-sirolimus) for adult and adolescent patients with solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
3 Locations
Trial ID
516-014
Sponsor ID
Mirati
A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location